- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Oregon is withdrawing its request for a closed drug formulary in the face of opposition from the drug industry and patient groups, but state Medicaid officials are still asking for permission to exclude accelerated approval drugs from its formularies until drug makers complete post-market studies, according to the state’s broader request that CMS waive certain Medicaid requirements.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us